Amy Yoder - Aug 19, 2024 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Director
Signature
Amy Yoder, by Attorney-in-fact, Solaeta Chan
Stock symbol
RKDA
Transactions as of
Aug 19, 2024
Transactions value $
$0
Form type
4
Date filed
8/21/2024, 07:41 PM
Previous filing
Jun 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RKDA Stock Option (Right to Buy) Award $0 +10.9K +430.68% $0.00 13.4K Aug 19, 2024 Common Stock 10.9K $2.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.